- About Us
- Our Story
- Our Products
- Our Science
- Our People
- Our Citizenship
-
Investors
- Reports and Filings
- Presentations
-
Shares
- Share Price
- Stock Updates
- Equity & Dividend History
- Unpaid & Unclaimed Dividend
- Analyst Coverage
- Shareholding Pattern
- Share Transfer Information
- Buyback
- Details of Shares for transfer to IEPF May 2018
- Notice pursuant to IEPF Rules, May 2018
- Details of Shares for transfer to IEPF May 2019
- Notice Pursuant to IEPF Rules, May 2019
- Details of Shares for transfer to IEPF May 2020
- Notice pursuant to IEPF Rules, May 2020
- Governance
- Investor Services
- Media
- Partners
- Canada
- Australia
- Germany
- India
- New Zealand
- China
- Netherlands
- Spain
- Contact Us
Statutory Communication
- Notice of Board Meeting Oct 14, 2004
- Board Meeting for audited financial results July 09, 2004
- Change in Cost Auditors June 04, 2004
- Notice of the Board Meeting under Clause 41 of the Listing Agreement May 14, 2004
- Norfloxacin Litigation Update; Disclosure under Clause 36(5) of the Listing Agreement May 11, 2004
- Board Meeting for audited financial results April 06, 2004
- Dr. Reddy's Announces ANDA Filing for Moxifloxacin tablets March 29, 2004
- Board Meeting on January 30 Jan 13, 2004
